The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 28, 2019
Filed:
Nov. 25, 2015
Applicant:
Takeda Pharmaceutical Company Limited, Chuo-ku, Osaka-shi, Osaka, JP;
Inventors:
Ryo Mizojiri, Kanagawa, JP;
Hiroshi Banno, Kanagawa, JP;
Moriteru Asano, Naruto, JP;
Daisuke Tomita, New York, NY (US);
Noriyuki Nii, Wakayama, JP;
Hironobu Maezaki, Kanagawa, JP;
Michiko Tawada, Kanagawa, JP;
Assignee:
TAKEDA PHARMACEUTICAL COMPANY LIMITED, Osaka, JP;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 413/04 (2006.01); C07D 413/14 (2006.01); A61K 31/343 (2006.01); A61K 31/381 (2006.01); A61K 31/416 (2006.01); A61K 31/423 (2006.01); A61K 31/428 (2006.01); A61K 31/437 (2006.01); A61K 31/443 (2006.01); A61K 31/4439 (2006.01); A61K 31/497 (2006.01); A61K 31/501 (2006.01); A61K 31/517 (2006.01); A61K 31/5377 (2006.01); C07D 231/56 (2006.01); C07D 333/56 (2006.01); C07D 401/04 (2006.01); C07D 403/04 (2006.01); C07D 405/04 (2006.01); C07D 413/12 (2006.01); C07D 417/04 (2006.01); C07D 471/04 (2006.01); C07D 263/54 (2006.01); C07D 498/04 (2006.01); C07D 307/81 (2006.01); C07D 263/57 (2006.01); C12N 15/09 (2006.01);
U.S. Cl.
CPC ...
C07D 413/04 (2013.01); A61K 31/343 (2013.01); A61K 31/381 (2013.01); A61K 31/416 (2013.01); A61K 31/423 (2013.01); A61K 31/428 (2013.01); A61K 31/437 (2013.01); A61K 31/443 (2013.01); A61K 31/4439 (2013.01); A61K 31/497 (2013.01); A61K 31/501 (2013.01); A61K 31/517 (2013.01); A61K 31/5377 (2013.01); C07D 231/56 (2013.01); C07D 263/54 (2013.01); C07D 263/57 (2013.01); C07D 307/81 (2013.01); C07D 333/56 (2013.01); C07D 401/04 (2013.01); C07D 403/04 (2013.01); C07D 405/04 (2013.01); C07D 413/12 (2013.01); C07D 413/14 (2013.01); C07D 417/04 (2013.01); C07D 471/04 (2013.01); C07D 498/04 (2013.01); C12N 15/09 (2013.01);
Abstract
Provided is a bicyclic compound having an acetyl-CoA carboxylase inhibitory action. A compound represented by the formula: wherein each symbol is as described in the DESCRIPTION, or a salt thereof has an acetyl-CoA carboxylase inhibitory action, is useful for the prophylaxis or treatment of cancer, inflammatory diseases and the like, and has superior efficacy.